Rene Russo Xilio Therapeutics, Inc. (XLO) insider trading activity

XLO Quotes by TradingView

Rene Russo is PRESIDENT AND CEO of Xilio Therapeutics, Inc.. Currently has a direct ownership of 281,172 shares of XLO, which is worth approximately $196,820. The most recent transaction as insider was on Jun 16, 2025, when has been sold 36,289 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $24,676. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 281K
14.82% 3M change
n/a 12M change
Total Value Held $196,820

Rene Russo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2025
BUY
Open market or private purchase
$24,676 $0.68 p/Share
36,289 Added 11.43%
281,172 Common Stock
Jan 01 2025
BUY
Exercise of conversion of derivative security
-
44,250 Added 15.3%
244,883 Common Stock

Also insider at

XFOR
X4 Pharmaceuticals, Inc Healthcare
Director
ADGI
Adagio Therapeutics, Inc. Healthcare
Director
RR

Rene Russo

PRESIDENT AND CEO
Boston, MA

Track Institutional and Insider Activities on XLO

Follow Xilio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLO shares.

Notify only if

Insider Trading

Get notified when an Xilio Therapeutics, Inc. insider buys or sells XLO shares.

Notify only if

News

Receive news related to Xilio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XLO